Kwabena F.M. Opuni

Dr. Kwabena F.M. Opuni

orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 July 2016 in Mass Spectrometry Reviews
Verified
Journal Article
Closed access
PDF file
KOKwabena F.M. Opuni
Kwabena F.M. Opuni
MAMahmoud Al‐Majdoub
Mahmoud Al‐Majdoub
YYYelena Yefremova
Yelena Yefremova
REReham El-Kased
Reham El-Kased
CKCornelia Koy
Cornelia Koy
MGMichael O Glocker
Michael O Glocker

25 August 2023 in Heliyon
Verified
Journal Article
Open access
KOKwabena F.M. Opuni
Kwabena F.M. Opuni
JKJames-Paul Kretchy
James-Paul Kretchy
KAKofi Agyabeng
Kofi Agyabeng
JBJoseph A. Boadu
Joseph A. Boadu
TATheodosia Adanu
Theodosia Adanu
IKIrene Akwo Kretchy
Irene Akwo Kretchy
The use of herbal medicinal products (HMPs) has grown significantly across low-and-middle-income countries (LMICs). Consequently, the safety of these products due to contamination is a significant public health concern. This systematic review aimed to determine the prevalence, types, and levels of contaminants in HMPs from LMICs. A search was performed in seven online databases, i.e., Africa journal online (AJOL), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Directory of Open Access Journals (DOAJ), Health Inter-Network Access to Research Initiative (HINARI), World Health Organization Global Index Medicus (WHO GIM), Scopus, and PubMed using appropriate search queries and reported as per the “Preferred Reporting Items for Systematic Reviews and Meta-Analyses” (PRISMA) guidelines. Ninety-one peer-reviewed articles published from 1982 to 2021 from 28 different countries across four continents were included in the study. Although metals, microbial, mycotoxins, pesticides, and residual solvents were the reported contaminants in the 91 articles, metals (56.0%, 51/91), microbial (27.5%, 25/91), and mycotoxins (18.7%, 17/91) were the most predominant. About 16.4% (1236/7518) of the samples had their contaminant levels above the regulatory limits. Samples tested for microbial contaminants had the highest proportion (46.4%, 482/1039) of contaminants exceeding the regulatory limit, followed by mycotoxins (25.8%, 109/423) and metals (14.3%, 591/4128). The proportion of samples that had their average non-essential metal contaminant levels above the regulatory limit was (57.6%, 377/655), 18.3% (88/480), 10.7% (24/225), and 11.3% (29/257) for Pb, Cd, Hg, and As, respectively. The commonest bacteria species found were Escherichia coli (52.3%, 10/19) and Salmonella species (42.1%, 8/19). This review reported that almost 90% of Candida albicans and more than 80% of moulds exceeded the required regulatory limits. HMP consumption poses profound health implications to consumers and patients. Therefore, designing and/or implementing policies that effectively regulate HMPs to minimize the health hazards related to their consumption while improving the quality of life of persons living in LMICs are urgently needed.

9 November 2021 in Preventive Medicine Reports
Verified
Journal Article
Open access
IKIrene A. Kretchy
Irene A. Kretchy
JBJoseph A. Boadu
Joseph A. Boadu
JKJames-Paul Kretchy
James-Paul Kretchy
KAKofi Agyabeng
Kofi Agyabeng
APAlfred A. Passah
Alfred A. Passah
KOKwabena F.M. Opuni
Kwabena F.M. Opuni
• 82.5% of all participants reported CAM use during the COVID-19 pandemic period. • 69.1% of CAM users intended it for COVID-19 infection prevention. • Commonly used CAM include vitamins, spiritual healing/prayer, minerals and herbals. • Age, sex and COVID-19 illness perception significantly predicted CAM use.

22 December 2020 in Tropical Medicine & International Health
Verified
Journal Article
Closed access
PDF file
IKIrene Akwo Kretchy
Irene Akwo Kretchy
AKAugustina Koduah
Augustina Koduah
KOKwabena F.M. Opuni
Kwabena F.M. Opuni
KAKofi Agyabeng
Kofi Agyabeng
TOThelma Ohene‐Agyei
Thelma Ohene‐Agyei
PNPrisca O. Ntow
Prisca O. Ntow

14 June 2017 in Journal of the American Society for Mass Spectrometry
Verified
Journal Article
Closed access
PDF file
YYYelena Yefremova
Yelena Yefremova
KOKwabena F.M. Opuni
Kwabena F.M. Opuni
BDBright Djan Danquah
Bright Djan Danquah
HTHans-Juergen Thiesen
Hans-Juergen Thiesen
MGMichael O Glocker
Michael O Glocker

1 August 2019 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
BDBright Djan Danquah
Bright Djan Danquah
CRClaudia Röwer
Claudia Röwer
KOKwabena F.M. Opuni
Kwabena F.M. Opuni
REReham El-Kased
Reham El-Kased
DFDavid Frommholz
David Frommholz
MGMichael O Glocker
Michael O Glocker
Epitope mapping, which is the identification of antigenic determinants, is essential for the design of novel antibody-based therapeutics and diagnostic tools. ITEM-THREE is a mass spectrometry-based epitope mapping method that can identify epitopes on antigens upon generating an immune complex in electrospray-compatible solutions by adding an antibody of interest to a mixture of peptides from which at least one holds the antibody′s epitope. This mixture is nano-electrosprayed without purification. Identification of the epitope peptide is performed within a mass spectrometer that provides an ion mobility cell sandwiched in-between two collision cells and where this ion manipulation setup is flanked by a quadrupole mass analyzer on one side and a time-of-flight mass analyzer on the other side. In a stepwise fashion, immune-complex ions are separated from unbound peptide ions and dissociated to release epitope peptide ions. Immune complex-released peptide ions are separated from antibody ions and fragmented by collision induced dissociation. Epitope-containing peptide fragment ions are recorded, and mass lists are submitted to unsupervised data base search thereby retrieving both, the amino acid sequence of the epitope peptide and the originating antigen. ITEM-THREE was developed with antiTRIM21 and antiRA33 antibodies for which the epitopes were known, subjecting them to mixtures of synthetic peptides of which one contained the respective epitope. ITEM-THREE was then successfully tested with an enzymatic digest of His-tagged recombinant human β-actin and an antiHis-tag antibody, as well as with an enzymatic digest of recombinant human TNFα and an antiTNFα antibody whose epitope was previously unknown. Graphical Abstract Highlights Multiplex epitope mapping/antigenic determinant identification in the gas phase. Intact transition and controlled dissociation of immune complexes by MS. Simultaneous identification and amino acid sequence determination of epitopes. Simplified in-solution sample handling because of ion manipulation and filtering by MS.